Apnimed, Inc. APMD
16.09 USD -1.16 (-6.70%)
Regular-session close
16.09 0.00 0.00%
After hours · Nov 20, 4:01 PM ET
15.95 Day range 17.73
14.16 52-week range 32.55
- YTD
- -35.64%
- 1 year
- -35.64%
5D +0.14 (+0.82%)
- Market cap
- 669.84M
- Revenue (ttm)
- 115.12M
- Profit margin
- 142.10%
- EPS (ttm)
- 13.34
- Shares out
- 41.63M
- P/E ratio
- 1.21
- Forward P/E
- -6.42
- YTD return
- -35.64%
- 1-year return
- -35.64%
- Volume
- 248.59K
- Avg volume
- 458.53K
- Open
- 17.08
- Previous close
- 17.25
- Day's range
- 15.95 – 17.73
- 52-week range
- 14.16 – 32.55
- Analysts
- Strong Buy
- Price target
- 50.33 (+212.8%)
- 50-day average
- 27.74
Key statistics
- 200-day average
- 27.74
- Enterprise value
- 1.25B
- Price / sales
- 9.23
- Revenue growth
- -29.40%
- Total cash
- 172.80M
- Total debt
- 80.35M
Fundamental scorecard
3 of 25 checks passed on APMD’s reported financials
3of 25 checks passed
- Value 0 of 5
- Growth 0 of 5
- Profitability No data
- Financial health 3 of 5
- Dividend No data
Statements to Sep 30, 2026.
Financials — quick view
APMD Revenue — quarterly 2.48M
APMD Net income — quarterly -29.52M
APMD EPS — quarterly -1.05
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Sep 8, 2026 | Jun 30, 2026 | -0.48667 | 3.92 | +4.41 | +905.47% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 25, 2026 | LifeSci Capital | init | — | Outperform |
| Aug 25, 2026 | Cantor Fitzgerald | init | — | Overweight |
| Aug 25, 2026 | Evercore ISI Group | init | — | Outperform |
| Aug 25, 2026 | B of A Securities | init | — | Buy |
About Apnimed, Inc.
Apnimed, Inc. operates as a clinical pharmaceutical company that develops and manufactures novel oral therapies that address the neurobiology of sleep-related breathing diseases in global markets. It offers AD109, an oral therapy designed to treat obstructive sleep apnea (OSA) by targeting the underlying neuromuscular dysfunction. The company was incorporated in 2017 and is headquartered in Cambridge, Massachusetts.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- apnimed.com
News
Your note
Sign in to keep a note on APMD — it syncs with the Stock Master app.
